The Transformation of the Pharmaceutical Industry Is Putting Pressure on Finland and Europe
Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
According to Mieli Ry, many young people have been left to face their worries alone for far too long. When the mind is overwhelmed, it can feel as though darkness engulfs everything. Mieli Ry strongly believes that by promoting mental health and preventing mental health problems, we can reduce the social, human, and financial costs associated with mental health disorders.
The mission of Mieli Ry is to safeguard the equal right of all individuals to good mental health. Mieli Ry is the world’s oldest non-governmental organization in the field of mental health.
Medaffcon wishes a peaceful and happy Christmas time to all our customers and stakeholders!
Companies are becoming increasingly selective about where they launch new medicines and where they invest in research.
Medaffcon’s Sales Lead Tomi "Tomppa" Vahevaara will retire on October 1st 2026. Tomppa leaves behind an exceptionally long career in the pharmaceutical industry spanning 45 years.
Medaffcon’s new Treatment Dynamics service provides insights into patient journeys, treatment progression, medication use and market dynamics through tailored patient-level real-world data analysis.